A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab
Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Online |
| Hizkuntza: | ingelesa |
| Argitaratua: |
International Association for Dental Research (Nigeria Division)
2019
|
| Sarrera elektronikoa: | https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Izan zaitez lehena ohar bat uzten!